Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sight Sciences (SGHT) EBIT (2020 - 2025)

Sight Sciences has reported EBIT over the past 6 years, most recently at -$3.7 million for Q4 2025.

  • Quarterly results put EBIT at -$3.7 million for Q4 2025, up 69.24% from a year ago — trailing twelve months through Dec 2025 was -$37.1 million (up 26.58% YoY), and the annual figure for FY2025 was -$37.1 million, up 26.58%.
  • EBIT for Q4 2025 was -$3.7 million at Sight Sciences, up from -$7.9 million in the prior quarter.
  • Over the last five years, EBIT for SGHT hit a ceiling of -$3.7 million in Q4 2025 and a floor of -$22.9 million in Q2 2022.
  • Median EBIT over the past 5 years was -$13.6 million (2023), compared with a mean of -$14.0 million.
  • Biggest five-year swings in EBIT: crashed 106.43% in 2022 and later soared 69.24% in 2025.
  • Sight Sciences' EBIT stood at -$14.7 million in 2021, then dropped by 15.88% to -$17.1 million in 2022, then skyrocketed by 34.85% to -$11.1 million in 2023, then decreased by 7.37% to -$11.9 million in 2024, then soared by 69.24% to -$3.7 million in 2025.
  • The last three reported values for EBIT were -$3.7 million (Q4 2025), -$7.9 million (Q3 2025), and -$11.7 million (Q2 2025) per Business Quant data.